UK markets close in 4 hours 25 minutes

Legend Biotech Corporation (LEGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.93+1.95 (+4.43%)
At close: 04:00PM EDT
46.15 +0.22 (+0.48%)
Pre-market: 05:27AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close43.98
Open44.50
Bid45.89 x 200
Ask45.98 x 100
Day's range43.65 - 45.97
52-week range42.08 - 77.32
Volume985,228
Avg. volume1,000,681
Market cap8.355B
Beta (5Y monthly)0.01
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

    Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line treatment.

  • Zacks

    Why Legend Biotech (LEGN) Stock Might be a Great Pick

    Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

  • Insider Monkey

    Should You Continue to Hold Legend Biotech Corporation (LEGN)?

    Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. Optimism started to prevail, during the last months of the year, and investors reacted positively to news of a potential change in direction by the US Federal Reserve, as well as […]